1,273
Views
15
CrossRef citations to date
0
Altmetric
Editorial

c9RAN translation: a potential therapeutic target for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia

, &
Pages 991-995 | Published online: 12 Jul 2013

Figures & data

Figure 1. Potential mechanisms of disease in c9FTD/ALS. Expansion of the GGGGCC hexanucleotide repeat within intron 1 of the C9ORF72 gene may cause c9FTD/ALS via RNA-dependent mechanisms. RNA transcripts resulting from transcription of GGGGCCexp aggregate into nuclear RNA foci that can sequester RNA-binding proteins and cause their loss of function. GGGGCCexp RNA transcripts are also susceptible to repeat-associated non-ATG translation, producing polyGA, polyGP and polyGR peptides, which form neuronal inclusions in c9FTD/ALS. Therapeutic strategies that target GGGGCCexp RNA transcripts may block both these putative pathogenic mechanisms. Moreover, while the mechanisms regulating RAN translation are poorly understood, and the means by which GGGGCCexp transcripts make their way to the cytoplasm are not yet known, targeting these events may also provide an approach to block RAN translation.

Figure 1. Potential mechanisms of disease in c9FTD/ALS. Expansion of the GGGGCC hexanucleotide repeat within intron 1 of the C9ORF72 gene may cause c9FTD/ALS via RNA-dependent mechanisms. RNA transcripts resulting from transcription of GGGGCCexp aggregate into nuclear RNA foci that can sequester RNA-binding proteins and cause their loss of function. GGGGCCexp RNA transcripts are also susceptible to repeat-associated non-ATG translation, producing polyGA, polyGP and polyGR peptides, which form neuronal inclusions in c9FTD/ALS. Therapeutic strategies that target GGGGCCexp RNA transcripts may block both these putative pathogenic mechanisms. Moreover, while the mechanisms regulating RAN translation are poorly understood, and the means by which GGGGCCexp transcripts make their way to the cytoplasm are not yet known, targeting these events may also provide an approach to block RAN translation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.